Cadherin cell-cell adhesion proteins play an important role in modulating the behavior of tumor cells. E-cadherin serves as a suppressor of tumor cell invasion, and when tumor cells turn on the expression of a non-epithelial cadherin, they often express less E-cadherin, enhancing the tumorigenic phenotype of the cells. Here, we show that when A431 cells are forced to express R-cadherin, they dramatically downregulate the expression of endogenous E-and P-cadherin. In addition, we show that this downregulation is owing to increased turnover of the endogenous cadherins via clathrin-dependent endocytosis. p120 ctn binds to the juxtamembrane domain of classical cadherins and has been proposed to regulate cadherin adhesive activity. One way p120 ctn may accomplish this is to serve as a rheostat to regulate the levels of cadherin. Here, we show that the degradation of E-cadherin in response to expression of R-cadherin is owing to competition for p120 ctn .
Introduction
Cells undergo a transition from an epithelial phenotype to a more mesenchymal phenotype to set in motion a number of normal developmental processes, including gastrulation in the vertebrate embryo (Thiery, 2002 ). An important aspect of this epithelial to mesenchymal transition is the loss of E-cadherin expression and an increase in the expression of non-epithelial cadherins, such as N-cadherin, cadherin-11 or R-cadherin. For example, expression of R-cadherin is necessary for the epithelial to mesenchymal transition that occurs in developing kidneys (Dahl et al., 2002) . It has been suggested that the epithelial to mesenchymal transition that occurs in some tumor cells as they become invasive is a recapitulation of the normal processes that occur during development (Thiery, 2002) . Our lab and others have shown that the expression of N-cadherin by epithelial tumor cells results in an epithelial to mesenchymal transition that is accompanied by increased motility and invasion (Islam et al., 1996; Nieman et al., 1999b; Hazan et al., 2000; Suyama et al., 2002) . In addition, non-epithelial cadherins, including Ncadherin, R-cadherin and cadherin-11, are expressed by some tumors in situ, and their expression has been correlated with high tumor grade and with an aggressive, metastatic phenotype (Islam et al., 1996; Pishvaian et al., 1999; Bussemakers et al., 2000; Giroldi et al., 2000; Tomita et al., 2000; Feltes et al., 2002) .
The dynamic nature of the adherens junctional complex allows epithelial cells to make and break connections with their neighbors as needed. One means cells use to ensure the dynamic nature of this junction is to continuously endocytose and recycle their cadherin/ catenin complexes (Le et al., 1999 (Le et al., , 2002 Akhtar and Hotchin, 2001; Palacios et al., 2001; Xiao et al., 2003b) . Various mechanisms and pathways have been proposed for cadherin recycling. It has been shown that confluent monolayers of Madin-Darby canine kidney (MDCK) cells constantly recycle a pool of detergent-soluble Ecadherin through an endocytic pathway that is clathrin dependent (Le et al., 1999) . These authors further showed that semiconfluent cells have an even higher proportion of recycling cadherin and that recycling of Ecadherin in MDCK cells is regulated by protein kinase C (Le et al., 2002) . Other investigations have shown that isolated cells, which cannot make contact because they have been plated at very low density, have increased cadherin recycling that is clathrin independent (Paterson et al., 2003) . Others have shown that when Srctransfected MDCK cells undergo an epithelial to mesenchymal transition, E-cadherin is internalized and routed to the lysosome for degradation, rather than being recycled, thus ensuring that contacts do not reform (Palacios et al., 2005) . In addition, when cells are transfected with dominant-negative cadherins, they rapidly turn over their endogenous cadherins, and in doing so, may employ some of the same mechanisms that are used in normal cadherin recycling (Nieman et al., 1999a; Xiao et al., 2003b) .
Cadherins bind to proteins called catenins that link the junctional complex to the cytoskeleton (a-and bcatenin), participate in cellular signaling (b-catenin and p120 ctn ) and/or regulate cadherin function (b-catenin and p120 ctn ). Recent studies have shown that one mechanism whereby p120 ctn regulates cadherin function is to serve as a rheostat to regulate cadherin levels (Davis et al., 2003; Peifer and Yap, 2003; Xiao et al., 2003a Xiao et al., , 2005 Kowalczyk and Reynolds, 2004) . When RNA interference (RNAi) was used to knock down the expression of p120 ctn , the endogenous cadherins were endocytosed and degraded. Likewise, when p120 ctn was overexpressed, cadherin levels rose accordingly (Davis et al., 2003; Xiao et al., 2003a) .
We and others have shown that expression of inappropriate cadherins contributes to tumorigenesis (Islam et al., 1996; Nieman et al., 1999b; Pishvaian et al., 1999; Hazan et al., 2000; Feltes et al., 2002; Suyama et al., 2002) . Our hypothesis for the present study was that when an epithelial cell inappropriately expresses Rcadherin, the normal E-cadherin recycling mechanisms are hijacked to divert the endogenous cadherins to a degradative pathway, resulting in the replacement of endogenous cadherins by the inappropriate cadherin. To test this hypothesis, we transfected A431 squamous epithelial cells, which express both E-and P-cadherin, with R-cadherin and investigated the fate of the endogenous cadherins. We show here that the Ecadherin recycling pathway is disrupted when A431 cells express R-cadherin and that endogenous cadherins undergo increased degradation. We further hypothesized that the increased degradation of E-cadherin was owing to preferential binding of p120 ctn to the exogenous R-cadherin. To test this, we mutated R-cadherin so that p120 ctn could no longer bind to it and showed that the mutant R-cadherin did not downregulate endogenous cadherins.
Results

R-cadherin expression in A431 cells downregulates endogenous cadherins
Studies from our lab and others have shown that expression of non-epithelial cadherins by epithelial cells can result in the downregulation of endogenous cadherins. The goal of this study was to further understand the mechanism whereby non-epithelial cadherins downregulates the expression of epithelial cadherins. We chose A431 cells for this study because they express two endogenous cadherins allowing us to determine if both cadherins were regulated in a similar manner. To avoid a bias that may be owing to clonal variations between cells, we employed retroviral transduction to produce populations of transfected cells rather than selecting individual clones. Control cells were populations of cells transduced with virus encoding the neomycin resistance gene. When R-cadherin-2 Â myc was expressed in A431 cells (A431R), it was localized to cell borders as expected ( Figure 1A , panel h) and the endogenous E-and P-cadherin were displaced from the plasma membrane to a cytosolic, punctate localization ( Figure 1A , panels f and g, respectively). Control A431Neo cells showed prominent plasma membrane localization of both E-and P-cadherin as expected. Immunoblots confirmed that steady-state levels of E-and P-cadherin were dramatically reduced in A431R cells ( Figure 1B ). There was no significant change in a-catenin, b-catenin or p120 ctn upon expression of R-cadherin. To confirm that downregulation of endogenous cadherins was not specific to A431 cells, we transduced BT20, a breast cancer cell line that expresses both E-and P-cadherin; HT1080, a fibrosarcoma cell line that expresses N-cadherin; and HaCaT, an immortalized keratinocyte cell line that expresses E-, Pand N-cadherin with virus encoding either the neomycin resistance gene alone or R-cadherin plus the neomycin resistance gene. In each case, the endogenous cadherins were downregulated ( Figure 1C ). Even in HaCaT cells, which endogenously express E-, P-and N-cadherin, all three endogenous cadherins were dramatically reduced. We have previously shown that the mobility of Ncadherin on sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) differs between different cell lines owing to differences in its glycosylation (Islam et al., 1996; Islam et al., 2000) , and this is apparent when comparing N-cadherin in HT-1080 cells to that in HaCaT cells.
We expected the ability of R-cadherin to decrease endogenous cadherins would be reversible. That is, if the A431R cells ceased to express R-cadherin, they would upregulate the expression of E-cadherin. To test this idea, we transfected A431R cells with Dharmacon smart pool RNAi oligoes against R-cadherin. As this was a transient transfection, the RNAi was not equally transfected into each cell in the dish. Thus, we used low-power microscopy ( Â 10 objective) to observe a large number of cells in the same field of view. Cells were co-immunostained for R-and E-cadherin to determine if cells that had decreased R-cadherin expression showed increased E-cadherin expression. Figure 1D (panels a and b) shows that the majority of the A431R cells that have been treated with control RNAi express R-cadherin (panel a) and very little E-cadherin (panel b). In contrast, A431R cells treated with RNAi against R-cadherin showed colonies of cells with decreased R-cadherin expression ( Figure 1D , panel c, pointed out by arrows). Importantly, these colonies showed increased expression of E-cadherin (panel d). The knock down of R-cadherin expression was not complete as clearly seen in panel c, but those cells in which R-cadherin was significantly decreased showed an increase in E-cadherin expression. Thus, knocking down R-cadherin effectively restored E-cadherin expression.
Although previous studies from our lab and others have suggested that cadherins are regulated at the level Endocytosis of cadherins M Maeda et al of protein turnover, it was important to rule out the possibility that exogenous expression of R-cadherin was influencing transcription of the endogenous cadherins. Thus, we performed real-time polymerase chain reaction (PCR) analysis on A431R and A431Neo cells to determine the levels of mRNA for E-cadherin, Pcadherin and several of the transcription factors that are known to repress E-cadherin transcription during epithelial to mesenchymal transitions (Snail, Slug and E12/47). Figure 2a shows that the levels of mRNA for E-cadherin, P-cadherin and each of the transcription factors were roughly equivalent between A431 cells and A431R cells, confirming that endogenous cadherin regulation was not at the level of mRNA. (A) R-cadherin-2 Â myc plus the neomycin resistance gene, or the neomycin resistance gene alone, were expressed in A431 cells using recombinant retrovirus (A431R and A431Neo, respectively). Panels a and e show phase micrographs of the cells. Rabbit anti-E-cadherin (panels b and f), mouse anti-P-cadherin (panels c and g) and mouse anti-myc (to detect R-cadherin; panels d and h) were used to localize cadherins. (B) A431R and A431Neo cells were extracted and 40 mg total protein was resolved by 7% SDS-PAGE, transferred to nitrocellulose and immunoblotted for R-cadherin, E-cadherin, P-cadherin, a-catenin, b-catenin, p120 ctn and GAPDH as a loading control. Molecular weight markers (MW) are indicated. (C) Rcadherin-2 Â myc plus the neomycin resistance gene, or the neomycin resistance gene alone, were expressed in BT-20 cells, HT1080 cells and HaCaT cells using recombinant retrovirus (BT-20Neo, BT-20R; HT1080Neo, HT1080R; HaCaTNeo, HaCaTR, respectively). Cells were extracted and 40 mg total protein was resolved by 7% SDS-PAGE, transferred to nitrocellulose and immunoblotted for Rcadherin, E-cadherin, P-cadherin or N-cadherin. (D) A431R cells were treated with RNAi to downregulate R-cadherin and co-stained with rabbit anti-E-cadherin and mouse anti-myc. Cells with decreased R-cadherin showed increased E-cadherin expression (arrows in panels c and d). Bar ¼ 10 mm.
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We next performed pulse-chase experiments to determine if the turnover of E-cadherin was more rapid in A431R cells than in A431Neo cells. Cells were pulsed with 35 S-methionine/cysteine and chased with cold methionine/cysteine. E-cadherin was immunoprecipitated, resolved by SDS-PAGE and autoradiographed to identify radioactive bands. At the 0 h time point, A431Neo cells and A431R cells produced approximately equal amounts of E-cadherin, with roughly equal amounts of the mature and proE-cadherin forms. A431R cells showed a more rapid turnover of E-cadherin than did A431 cells, with the majority of the E-cadherin degraded by the 8 h time point (Figure 2b and c). By contrast, significant levels of E-cadherin were still present in the A431Neo cells even at the 24 h time point. Similar results were seen for P-cadherin (data not shown).
Cytosolic E-cadherin co-localizes with lysosomal markers Immunofluorescence analysis of A431R cells revealed an increase in punctate structures in the cytoplasm that were positive for E-and P-cadherin ( Figure 1A , panels f and g). These structures were not present in A431Neo cells, although smaller, presumably synthetic and/or recycling vesicles were evident. This static picture could not distinguish between endogenous cadherin that was newly synthesized and destined for the cell surface and endocytosed cadherin that was destined either for recycling or degradation. To distinguish these two possibilities, we performed immunofluorescence colocalization experiments using rabbit anti-E-cadherin antibodies and mouse antibodies against a lysosomal marker (Lamp-1) or a Golgi marker (mannosidase II). There was extensive co-localization of E-cadherin with Lamp-1-positive vesicles (Figure 3 , panels d-f) and limited co-localization with mannosidase II-positive vesicles (Figure 3 , panels g-i), suggesting that the vesicles were endocytic rather than synthetic. Arrows in panels d-f point out selected co-localizing vesicles. By contrast, there was virtually no detectible co-localization of E-cadherin with Lamp-1 in control A431Neo cells (Figure 3 , panels a-c).
It has been suggested that multiple pathways exist for endocytosis of E-cadherin (D'Souza-Schorey, 2005) . In confluent cells, the cadherin is endocytosed via a clathrin-dependent pathway and recycled back to the plasma membrane (Le et al., 1999) . However, when cells are plated sparsely so that they do not have contact with one another and cannot interact via E-cadherin, the cadherin is endocytosed through a clathrin-independent pathway resembling macropinocytosis (Paterson et al., 2003) . To determine the mechanism of endocytosis of Ecadherin in A431R cells, we used immunofluorescence to co-localize the cadherin with markers for endocytosis. Figure 4A (panels a-c) shows that E-cadherin colocalizes with the early endosomal marker, EEA-1. Figure 4A (panels g-i) shows that it also extensively colocalizes with clathrin, whereas Figure 4A (panels d-f) shows it does not co-localize with caveolin-1, suggesting that in these cells, E-cadherin is endocytosed via a clathrin-dependent mechanism. This is in agreement with Xiao et al. (2005) , who recently showed that VEcadherin is endocytosed via a clathrin-dependent pathway in human microvascular endothelial cells. To confirm that R-cadherin promoted E-cadherin endocytosis through a clathrin-dependent mechanism, we inhibited clathrin-dependent endocytosis by potassium depletion as described (Xiao et al., 2005) , except that we depleted potassium for 1.5 h to allow the cells sufficient ÀDDCt . The amount of target RNA was normalized to endogenous GAPDH. There was no significant difference in the levels of any of these RNAs when comparing A431Neo to A431R cells. (b) E-cadherin is turned over more rapidly in A431R cells than in A431Neo cells. Cells were pulse-labeled with 35 S-Translabel for 30 min and chased with medium for the indicated times. Cell extracts were made at each time point and immunoprecipitated with mouse anti-E-cadherin. Immunocomplexes were resolved by 7% SDS-PAGE, proteins were transferred to nitrocellulose and exposed to film at À801C. E-cadherin is synthesized as a proprotein and the pro-sequence is removed during biosynthesis. ProE-cadherin is pointed out at the 0 h time point. Molecular weight markers are indicated. (c) Films from three independent experiments were scanned, quantified and graphed.
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M Maeda et al time to accumulate a detectible level of E-cadherin on their surface. We then processed the cells for immunofluorescence without permeabilization in order to observe only the E-cadherin on the cell surface. Figure 4B (panels a and b) shows surface E-cadherin staining of untreated or potassium-depleted cells, respectively. When clathrin-dependent endocytosis was inhibited, E-cadherin accumulated on the cell surface ( Figure 4B, panel b) . To confirm that the cells indeed were non-permeabilized and we were observing only cell surface E-cadherin, we also stained treated or untreated cells with an antibody against the cytoplasmic domain of E-cadherin ( Figure 4B , panels c and d, respectively). There was little to no detectible signal, indicating that the plasma membranes were intact. Figure 4B (panels e and f) depicts untreated or potassium-depleted cells, respectively, that were allowed to take up Texas redlabeled transferrin for 15 min post-treatment. Untreated cells were able to take up transferrin, as evidenced by the punctate vesicles within the cells, whereas potassiumdepleted cells were defective in transferrin uptake, indicating that clathrin-mediated endocytosis was indeed inhibited by the treatment. Cadherins are present on the surface of the cell as a complex with catenins, which provides linkage to the cytoskeleton. It has been shown that, in MDCK cells, Ecadherin is continuously endocytosed and recycled to the cell surface (Le et al., 1999 (Le et al., , 2002 . In these studies, b-catenin was recycled together with E-cadherin. In the present study, we are suggesting that E-cadherin is endocytosed and degraded, not recycled, when cells express R-cadherin. As the fate of E-cadherin is very different in our system, it was not clear how the associated b-catenin might be dealt with. Thus, we were interested in whether catenins were co-endocytosed with the cadherin or if they remained at the cell surface. In control A431Neo cells, p120
ctn , a-catenin and b-catenin co-localized with E-cadherin at cell borders ( Figure 5A) . In A431R cells, p120 ctn , a-catenin and b-catenin showed limited co-localization with the internalized E-cadherin, whereas the majority of all three catenins remained at cell borders ( Figure 5B) , presumably owing to their interactions with R-cadherin ( Figure 5C ).
R-cadherin-induced degradation of endogenous cadherins is owing to competition for p120 ctn
The above data is reminiscent of that reported by two separate laboratories investigating the role of p120 ctn in cadherin stabilization (Davis et al., 2003; Xiao et al., 2003b Xiao et al., , 2005 . These studies reported that knocking down p120 ctn using RNAi resulted in the degradation of the cadherins in a number of cell types, including epithelial cells and endothelial cells. Thus, we hypothesized that expressing an inappropriate cadherin by tumor cells may promote the degradation of epithelial cadherins by competing for the available p120 ctn . To test this hypothesis, we used an R-cadherin construct that could not interact with p120
ctn . E-cadherin with a triple alanine mutation in the p120 ctn -binding site has been shown to prevent p120 ctn binding (Thoreson et al., 2000) . Sequence alignment of R-and E-cadherin revealed a similar sequence in the presumed p120 ctn -binding site (Thoreson et al., 2000) . Thus, we constructed Rcadherin with a triple A mutation in the presumed p120 ctn -binding site, which we designated R(AAA)-cadherin. Figure 6A shows that R(AAA)-cadherin is highly expressed in A431 cells (top panel) and that antibodies against the myc tag (to pull down myc-tagged R-cadherin) do not pull down p120 ctn (bottom panel). Thus, mutating the presumed p120 ctn -binding site in Rcadherin effectively abolished its association with p120 ctn , as expected. The control A431Neo cells do not express R-cadherin, so there was no p120 ctn in the immunoblot, as expected. Abundant p120 ctn co-immunoprecipitated with R-cadherin from extracts of A431R cells, whereas virtually no p120 ctn co-immunoprecipitated with R-cadherin in cells expressing R(AAA)-cadherin. Figure 6B shows by immunofluorescence that R(AAA)-cadherin does not downregulate E-cadherin (panel g). The myc-tagged versions of wild-type Rcadherin and R(AAA)-cadherin were at cell borders (panels e and h), as was p120 ctn (panels f and i). Figure 6C further demonstrates that R(AAA)-cadherin did not significantly downregulate E-or P-cadherin in A431 cells by comparing immunoblots of whole-cell extracts of A431Neo, A431R and A432R(AAA) cells. Eand P-cadherin levels were significantly decreased in A431R cells but not in A431R(AAA) cells. We also Figure 6C (right panel) shows that p120 ctn levels did not change when the cells expressed wild-type or mutant R-cadherin.
Discussion
When E-cadherin function is perturbed, tumor cells gain invasive characteristics. In vivo and in vitro studies have shown that when the function of E-cadherin is inhibited, whether by using inhibitory antibodies to block function or molecular mechanisms to block expression, normal epithelial cells are converted to invasive cells. In addition, numerous studies have shown that E-cadherin expression is decreased in invasive carcinomas, and many laboratories have contributed to our understanding of mechanisms influencing the activity of E-cadherin in tumors. Thus, it is well established that regulation of E-cadherin expression plays a significant role in carcinogenesis (reviewed in Behrens, 1999; Guilford, 1999; Wheelock et al., 2001; Thiery, 2002; Wheelock and Johnson, 2003; Kang and Massague, 2004; Vernon and LaBonne, 2004) .
Epithelial to mesenchymal transitions typically involve cadherin switching, usually from the expression of an epithelial cadherin such as E-cadherin to a cadherin more likely to be associated with mesenchymal cells, such as N-or R-cadherin. During normal development, epithelial to mesenchymal transitions are regulated by transcription factors such as snail that function as suppressors of E-cadherin expression. Whether or not the same fundamental mechanisms regulate the suppression of E-cadherin during tumorigenesis is controversial. Our lab and others have shown that some tumors express cadherins that are not appropriate for epithelial tissues (Islam et al., 1996; Hazan et al., 1997; Pishvaian et al., 1999; Feltes et al., 2002) . In addition, when epithelial cells are forced to express non-epithelial cadherins, the expression level of E-cadherin is usually reciprocally decreased, and this does not involve gene repression, but rather is mediated by protein turnover (Figures 1 and 2 
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M Maeda et al Johnson et al., 2004) . Although the mechanisms for decreasing expression of E-cadherin have been deciphered, including gene repression, gene inactivation or protein turnover, what turns on the expression of an inappropriate cadherin during tumorigenesis is not at all understood. This is a critical area of research if we are to develop mechanisms to manipulate cadherin expression during tumor treatment.
In this study, we showed that E-cadherin is degraded when A431 cells express R-cadherin, most likely because there is limiting p120 ctn and the p120 ctn binds to the exogenously expressed R-cadherin. This may be owing to a more rapid synthetic rate for the exogenous gene or to preferential binding of p120 ctn to R-cadherin. p120 ctn is expressed as multiple splice forms that exhibit cell-type preference. In particular, isoform 1 is preferentially expressed by fibroblastic cells, whereas isoform 3 is preferentially expressed by epithelial cells (Reynolds and Roczniak-Ferguson, 2004 ). Ohkubo and Ozawa (2004) showed that the expression of the E-cadherin transcriptional repressor, snail, in MDCK cells resulted in a switch from the epithelial isoform of p120 ctn to the fibroblastic isoform. We did not see a consistent p120 ctn isoform switch in cells expressing R-cadherin. Figure 1 shows a slightly higher expression of the fibroblastic form (the more slowly migrating p120 ctn band); however, this was not consistently seen and there is still significantly more of the faster migrating isoform (the epithelial-specific p120 ctn isoform).
Another possibility is that non-epithelial cadherins like N-and R-cadherin are better stabilized by p120 ctn than is E-cadherin. Although we have no direct evidence that non-epithelial cadherins are better stabilized by p120 ctn , we have shown that N-cadherin binds to p120 ctn as it is synthesized, whereas others have shown that p120 ctn binds to E-cadherin after the E-cadherin is at the membrane (Miranda et al., 2003) . R-cadherin is highly homologous to N-cadherin and early binding of p120 ctn may be true for this cadherin also. If this is the case, then we could hypothesize that in A431R cells, the p120 ctn is bound by R-cadherin early in the synthetic process and is not available to stabilize E-cadherin. Further studies to identify differential binding of cadherins to p120 ctn await the generation of new reagents required for these studies, such as antibodies that specifically recognize immature forms of the cadherins like those we have generated against immature N-cadherin (Wahl et al., 2003) .
An emerging story is the fate of E-cadherin in epithelial cells as adherens junctions break and form during carcinogenesis (D'Souza-Schorey, 2005) . As many tumor cells have normal cadherin gene expression but appear to deregulate cadherin function by posttranslational mechanisms, it will be important to fully understand the pathway of E-cadherin endocytosis and destruction. Recent studies have made it clear that adhesive activity of cadherins is controlled in a cell- 
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context-dependent manner. For example, N-cadherin promotes strong cell adhesion in some cell types, such as cardiac muscle, but promotes motility and cell scattering in other cells. Whether or not endocytosis and destruction of cadherins follows the same route when induced by different signals remains to be seen.
Materials and methods
Materials
All reagents were purchased from Sigma Chemical Company (St Louis, MO, USA), unless otherwise indicated.
Cell culture
The human breast cancer cell line BT-20 was maintained in minimal essential medium supplemented with 10% fetal calf serum (FCS; Hyclone Laboratories, Logan, UT, USA). Phoenix, A431, HT1080 and HaCaT cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% FCS. Culture medium was supplemented with 50 U/l penicillin and 50 mg/l streptomycin. Where appropriate, cells that were infected with recombinant retroviruses were maintained in culture medium supplemented with 1 mg/ml G418 (Cellgro, Herndon, VA, USA) or 2 mg/ml puromycin.
Molecular constructs
Constructs derived from in vitro DNA synthesis and PCR products utilized in any of the constructions described below were sequenced and shown to contain only the intended changes. The mouse R-cadherin cDNA (GenBank D14888) was a kind gift from Dr Masatoshi Takeichi, RIKEN Center for Developmental Biology, Kobe, Japan (Matsunami et al., 1993) . Using PCR, the R-cadherin stop codon was replaced with a ClaI site allowing insertion into a derivative of pSPUTK (Falcone and Andrews, 1991) that added a Cterminal 2 Â myc tag. The modified cDNA was then inserted into LZRS-MS-Neo (Ireton et al., 2002) . The R-cadherin mutant that does not bind p120 ctn was generated using a QuickChange site-directed mutagenesis kit. The amino-acid alterations, E787A, E788A and D789A, correspond to those found effective in uncoupling E-cadherin from p120 ctn (Thoreson et al., 2000) .
PCR
For quantitative real-time PCR, total RNA was isolated from cells using TRIzol reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). Samples were treated with DNA-free TM according to the manufacturer's instructions (Ambion, Austin, TX, USA) to remove any contaminating DNA. The concentration and quality of the RNA in each sample were determined by absorbance at 260 nm. RNA (1 mg) was analysed in an Mx3000Pt real-time PCR System (Stratagene, La Jolla, CA, USA) as follows: 501C for 30 min and 951C for 10 min, followed by 45 cycles at 951C for 30 s and 601C for 1 min. Combinations of primers and probes for E-cadherin, P-cadherin, E12/47, snail, slug and GAPDH (control) were purchased from Applied Biosystems (Foster City, CA, USA). The reaction mixture was made using Brilliant s Probe-Based QRT-PCR Reagents (Stratagene) according to the manufacturer's instructions. Reactions were performed a total of six times from two separate RNA preparations. Relative mRNA values were obtained using the comparative method using the formula 2
ÀDDCt . The amount of target RNA was first normalized to endogenous GAPDH and then the relative levels compared between cell lines.
Transfection, virus production and infection Phoenix cells (Grignani et al., 1998) were transfected using a calcium phosphate transfection kit (Stratagene) with LZRS-MS-Neo or the same vector with the various R-cadherin constructs (Ireton et al., 2002) and selected in 2 mg/ml puromycin. Cells were cultured until confluent, split and stored in liquid nitrogen. Transfected Phoenix cells were grown at 371C in selective medium until 50-80% confluent, at which time the medium was replaced with fresh medium without puromycin and cells were grown overnight at 321C. Viruscontaining medium was removed, filtered through a 0.45 mm filter and supplemented with polybrene (4 mg/ml). Target cells were plated overnight at low density to ensure single cells and , d and g ), against the myc tag (to detect R-cadherin; panels b, e and h) or against p120 ctn (panels c, f and i). Bar ¼ 10 mm. (C) E-cadherin is not downregulated in A431R(AAA) cells. Protein (50 mg) from extracts of A431Neo, A431R and A431R(AAA) were immunoblotted with antibodies against the myc tag (to detect the tagged R-cadherin), E-cadherin, P-cadherin and p120 ctn .
Endocytosis of cadherins M Maeda et al then incubated in the virus-containing media at 321C for 2-6 h. Infected cells were cultured until approximately 80% confluent and then selected in 1 mg/ml G418. R-cadherin expression was downregulated by treatment with Dharmacon Smartpool RNAi as directed by the manufacturer.
Antibodies
The monoclonal antibody against human E-cadherin (HECD-1) was kindly provided by Dr Masatoshi Takeichi. Rabbit polyclonal antibodies against human E-cadherin (Jelly) have been described (Wheelock et al., 1987) . Monoclonal antibodies against human N-cadherin (13A9), human P-cadherin (6A9), a-catenin (1G5) and b-catenin (15B8) have been described (Knudsen and Wheelock, 1992; Johnson et al., 1993; Sacco et al., 1995) . The mouse monoclonal antibody against the myc epitope (9E10) was a kind gift from Dr Kathleen Green (Northwestern University, Chicago, IL, USA). Mouse monoclonal antibodies against p120 ctn , caveolin-1, clathrin and EEA-1 were purchased from BD Transduction Laboratories (Two Oak Park, Bedford, MA, USA). The mouse monoclonal antibody against CD107a (Lamp-1) was purchased from RDI (Flanders, NJ, USA). The rabbit polyclonal antibody against mannosidase II was purchased from Chemicon International (Temecula, CA, USA). FITC-and TRITC-conjugated antimouse and anti-rabbit secondary antibodies were purchased from Jackson Immuno Research Laboratory (West Grove, PA, USA). The rabbit polyclonal antibody against the myc tag was purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Secondary antibodies used for Western blot analysis were horseradish peroxidase-conjugated anti-IgG (Jackson Immuno Research Laboratory).
Immunofluorescence, cell extraction and immunoprecipitation Cells plated on glass coverslips were fixed and stained as described (Wahl et al., 2003) , viewed on a Zeiss Axiovert 200 M equipped with an ORCA-ER (Hamamatsu) digital camera and processed using OpenLab software (Improvision Inc.). For immunofluorescence experiments with non-permeabilized cells, the cells were fixed for 15 min in 3.7% formaldehyde-HEPES/ Hanks, blocked for 10 min and incubated in primary antibodies followed by secondary antibodies for 20 min in a humid chamber. Confluent cell monolayers were extracted and immunoprecipitated as described (Wahl et al., 2003) . The pellets were resuspended in 2 Â Laemmli buffer and subjected to SDS-PAGE (Laemmli, 1970) . Potassium depletion was carried out as described (Subtil et al., 1994 ) using a calcium containing buffer (Muro et al., 2003) to preserve cadherin cellcell contacts, for 1.5 h. Texas red-labeled transferrin (Molecular Probes, Eugene, OR, USA) was added 15 min before stopping the experiment.
Trans
35 S pulse/chase analysis Culture medium from 75-80% confluent monolayers was replaced with methionine/cysteine-deficient DMEM supplemented with 1% dialysed FCS for 4 h, and then replaced with fresh medium containing 250 mCi Trans 35 S label (ICN Biochemicals, Irvine, CA, USA) for 30 min. Monolayers were washed in DMEM containing 10% FCS, chased for 4-12 h and extracted as above. Cell extract was immunoprecipitated, immunocomplexes were resolved by SDS-PAGE and proteins were transferred to nitrocellulose, which was exposed to film at À801C for 3 days.
